Obesity Pathway Intelligence

Turn obesity population data into structured pathway action.

A workflow-led platform for NHS practices, PCNs and ICBs. Identify data quality gaps, activate weight-management pathways, review GLP-1/tirzepatide opportunity, prioritise high-need patients and surface safety/caution cohorts — all from one structured workspace.

Request a Demo Discuss Your Obesity Pathway

Built for NHS primary care workflows. Supports clinical review, pathway planning and operational prioritisation. Does not replace clinician judgement.

Pathway modules

12+

Insight worklists

Levels: Practice · PCN · ICB

Pathway Map Worklists Population

Numerator cohort identified
312 patients in TA1026 review group

Safety/caution flags
GLP-1 + DPP4 review · 18 patients

NHS Pathway Challenge

Obesity pathway delivery is becoming an operational challenge.

Practices, PCNs and ICBs are not short of obesity data — they are short of usable pathway intelligence. Static prevalence reporting cannot drive the structured action needed across data quality, weight-management pathways, GLP-1/tirzepatide review, prioritisation and safety.

Rising clinical burden

Obesity now intersects with diabetes, cardiovascular disease, sleep apnoea, fatty liver, mental health and inequalities — driving avoidable demand across the NHS.

Complex pathway requirements

Effective obesity care needs sequencing across coding, advice, referral, pharmacotherapy review and safety — not single-step prescribing or a static register.

GLP-1/tirzepatide implementation pressure

NICE TA1026 and NHS England interim commissioning guidance make pharmacotherapy pathway review a live operational need — not just a prescribing decision.

Equitable prioritisation

Deprivation, comorbidity burden and clinical complexity vary widely. Teams need clear ways to surface higher-need cohorts so finite capacity is used fairly.

Patient-level worklists, not searches

Practices waste time stitching together saved searches and spreadsheets. They need ready-made worklists with cohort context, recommendation and status tracking.

PCN and ICB oversight

Networks and systems need consistent visibility across practices — for variation, deprivation, capacity planning and pathway commissioning.

Platform Workflow

From population to pathway action.

A single consolidated obesity population, branched into the five pathway modules NHS teams actually work through — with example cohorts surfaced as patient-level worklists.

Root cohort

All Obesity Population

One consolidated view of patients with obesity and relevant clinical, demographic and pathway markers.

Stage 1

BMI Data Quality

Rebuild a clean foundation: recent BMI, accurate obesity coding, validated population.

BMI not recorded in last 12 months BMI obesity range but no obesity code

Stage 2

Pathway Activation

Surface candidates whose pathway has not been activated through advice or referral.

No recorded weight-management advice No recorded weight-management referral Tier 3 / Tier 4 visibility

Stage 3

GLP-1 / Tirzepatide Review

Review pharmacotherapy pathway opportunity against NICE TA1026 and phased access criteria.

Potential NICE TA1026 candidate ICG phased cohort, not on GLP-1 Already on GLP-1 therapy

Stage 4

Prioritisation

Use deprivation, comorbidity load and risk markers to focus capacity on higher-need cohorts.

High-deprivation ICG candidates Obesity with multiple comorbidities

Stage 5

Safety / Caution

Surface medication-context and clinical caution groups for structured review.

GLP-1 with DPP4 safety flag GLP-1 with insulin / sulfonylurea Pancreatitis / gallbladder caution

Product Tour

See the platform in action.

Five core surfaces that move teams from population intelligence to operational pathway action — click through each below.

Obesity Pathway Map

A family-tree view of the obesity pathway

See how the obesity population flows through data quality, activation, GLP-1/tirzepatide review, prioritisation and safety, with cohort counts at every stage.

Insight worklist with patient-level rows and clinical context

Patient-level workflow worklists

Each insight opens as an operational review list with cohort context, clinical detail and recommendation tracking — ready for MDT or pharmacist-led review.

Obesity population table with comorbidity, BMI and pathway markers

A full patient-level population view

BMI, weight, comorbidities, medications, pathology and pathway markers in one explorable table — for validation, segmentation and local planning.

Bulk recommendations, actions and statuses

Apply recommendations and statuses across selected cohorts to drive consistent team workflow at practice and PCN scale.

Clinical guideline context within the obesity insight platform

Clinical context built in

Built-in NICE and NHS guidance, clinical rationale and interpretation notes keep pathway decisions grounded in current best practice.

Platform Capabilities

Everything needed to move from insight to action.

Six structured capabilities that turn obesity population data into a managed pathway workflow, not just a static dashboard.

Pathway Map

Visualise the full obesity population segmented across data quality, activation, pharmacotherapy review, prioritisation and safety.

Actionable Worklists

Open each insight as a patient-level worklist with recommendation, action and status tracking for clinical and admin teams.

Patient-Level Population View

Explore BMI, weight, comorbidities, medications, pathology and pathway markers in one structured population table.

GLP-1 / Tirzepatide Pathway Review

Identify patients who may need review against NICE TA1026 broad criteria and NHS England phased access cohorts.

Prioritisation & Inequalities

Surface deprivation and comorbidity-based priority groups to support equitable obesity pathway planning at scale.

Safety / Caution Review

Highlight medication-context and clinical caution groups (e.g. GLP-1 + DPP4) for structured review and governance support.

Built For Practices, PCNs & ICBs

Built for the way NHS teams actually deliver obesity care.

Practical value at every level of the system — from the GP practice clinical team, to the PCN coordinating delivery, to the ICB planning at population scale.

For GP Practices

Operational obesity worklists

Find patients needing BMI updates, coding review or activation.
Open worklists with recommendation, action and status tracking.
Reduce manual searches, ad hoc spreadsheets and repeat work.
Move from data to action without leaving NHS-aligned workflow.

Example: a pharmacist-led obesity review session opens the “ICG cohort, not on GLP-1” worklist, applies recommendation statuses and tracks pathway readiness.

Book a practice walkthrough

For PCNs

Coordinated pathway delivery

Coordinate obesity pathway work across member practices.
Identify variation and target high-value cohorts at PCN scale.
Direct workforce effort — pharmacists, HCAs, care coordinators.
Understand cohort scale before pathway rollout.

Example: a PCN obesity lead uses the prioritisation view to focus a borough pharmacist team on high-deprivation candidates not currently activated.

Discuss PCN delivery

For ICBs

System-level pathway oversight

Understand obesity burden and pathway opportunity at scale.
Monitor variation and inequalities across places and networks.
Support pathway commissioning and service planning.
Inform phased TA1026 implementation and prioritisation.

Example: an ICB long-term conditions team uses the prioritisation and inequalities view to plan equitable rollout of pharmacotherapy services across networks.

Talk to our ICB team

Use Cases

What teams can do with Obesity Pathway Intelligence.

Common, practical scenarios — from data quality recovery to safe deployment of pharmacotherapy pathways.

Find patients without a recent BMI

Surface obesity-coded patients without a BMI in the last 12 months for recall and review.

Resolve obesity coding gaps

Identify patients whose BMI suggests obesity but who have no obesity code recorded.

Activate weight-management pathways

Identify candidates without recorded advice or referral and prepare review lists for action.

Review GLP-1/tirzepatide opportunity

Surface ICG phased-access candidates and broad TA1026 review groups not currently on therapy.

Prioritise high-deprivation cohorts

Focus capacity on higher-need cohorts to support equitable rollout and pathway planning.

Support medication-context safety review

Highlight GLP-1 + DPP4, GLP-1 + insulin/SU and pancreatitis/gallbladder caution groups for structured review.

How It Works

How Obesity Pathway Intelligence fits NHS data workflows.

Designed around structured data extracts and refreshed insight snapshots. Supports clinical review and pathway planning — it does not write back to clinical systems or replace clinician decisions.

Step 01

Data import

Practice data extracts are securely imported and structured for obesity pathway analysis.

Step 02

Insight generation

Pathway logic is applied to produce structured patient-level cohorts and refreshed insight snapshots.

Step 03

Pathway review

Teams use the Pathway Map, worklists and population view to prioritise pathway action.

Step 04

Action tracking

Recommendations, actions and statuses are captured in the platform to support team workflow.

NHS-Aware Platform Design

Designed for NHS primary care data workflows.

Built by a team with deep experience of NHS primary care data, EMIS Web and SystmOne extract workflows, SNOMED-led clinical definitions and structured insight delivery.

NHS primary care expertise

Built around the realities of practice data, registers, coding and pathway delivery.

EMIS / SystmOne extracts

Structured data extract workflows, no need for live write-back into clinical systems.

SNOMED-led definitions

Clinical cohorts built on terminology and methodology designed for NHS use.

UK GDPR-aware operating model

Operates in line with NHS data security expectations. Clinical review support — not automated prescribing.

Deployment Models

Flexible deployment for local pathway priorities.

The platform supports practice-level adoption, PCN/ICB pathway models and governance-compliant service-enablement programmes — aligned to NHS expectations and local approvals.

How teams typically deploy

Three common deployment patterns — designed to fit how NHS organisations actually plan, fund and manage obesity pathway delivery.

Practice-level adoption for local pathway delivery.
PCN or ICB roll-out for coordinated network delivery.
Industry-supported pathway enablement — subject to NHS governance.
Service transformation and patient activation programmes.

Partnership and funded pathway programmes are scoped on a case-by-case basis with clear NHS governance, local approvals and data protection arrangements. The platform itself does not provide pharma access to patient-identifiable data.

Ready to see your obesity pathway population clearly?

Whether you are a practice looking for actionable worklists, a PCN coordinating pathway delivery, or an ICB planning obesity services at scale — Obesity Pathway Intelligence helps turn population data into structured pathway action.

Request a Demo Discuss Your Local Pathway